Cleared Traditional

K061820 - DIASORIN LIAISON VZV IGG (FDA 510(k) Clearance)

Feb 2007
Decision
243d
Days
Class 2
Risk

K061820 is an FDA 510(k) clearance for the DIASORIN LIAISON VZV IGG. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Varicella-zoster (Class II - Special Controls, product code LFY).

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on February 26, 2007, 243 days after receiving the submission on June 28, 2006.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3900.

Submission Details

510(k) Number K061820 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2006
Decision Date February 26, 2007
Days to Decision 243 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LFY — Enzyme Linked Immunoabsorbent Assay, Varicella-zoster
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3900